207_Combined course Presentations

Challenges for CAR Therapy

• Limitation: Antigen targets with surface expression are often not specific

• More specific targets are intracelullar (NYESO-1)

• Heterogenous expression of tumor antigen in solid tumors

• Suppressive tumor microenvironment factors

• Highly TOXIC

• Expensive (personalized) and infrastructure is required